Home/Filings/4/0001078782-20-000012
4//SEC Filing

TERRELL JASON BRADLEY MD 4

Accession 0001078782-20-000012

CIK 0000093314other

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 2:10 PM ET

Size

5.0 KB

Accession

0001078782-20-000012

Insider Transaction Report

Form 4
Period: 2020-01-12
TERRELL JASON BRADLEY MD
Chief Medical Officer
Transactions
  • Disposition to Issuer

    Common Stock

    2020-01-12$4.79/sh11,364$54,43450,000 total
Footnotes (1)
  • [F1]The reported transaction, consisting of the Issuer's repurchase of shares of common stock from the Reporting Person, was approved by the compensation committee of the Board of Directors (comprised of three "non-employee directors") and, pursuant to Rule 16b-3(e), is exempted from matching for purposes of Section 16(b) of the Exchange Act.

Issuer

VOLITIONRX LTD

CIK 0000093314

Entity typeother

Related Parties

1
  • filerCIK 0001567531

Filing Metadata

Form type
4
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 2:10 PM ET
Size
5.0 KB